CW-2Homo sapiens (Human)Cancer cell line

Also known as: CW2

🤖 AI SummaryBased on 7 publications

Quick Overview

Human cancer cell line for research on genetic and molecular mechanisms.

Detailed Summary

The CW-2 cell line is a human-derived cancer cell line used in various research applications. It is characterized by its genetic and molecular profiles, which make it suitable for studying cancer biology and drug responses. The cell line has been utilized in studies involving transcriptomic and genomic analyses to understand cancer progression and therapeutic strategies. Research on this cell line has contributed to the identification of gene fusions, mutations, and other genomic alterations that are relevant to cancer development and treatment. The CW-2 cell line is part of larger panels of cancer cell lines that are used to model different aspects of cancer biology, providing insights into the heterogeneity of cancer and the development of targeted therapies.
Generated on 6/16/2025

Basic Information

Database IDCVCL_1151
SpeciesHomo sapiens (Human)
Tissue SourceColon[UBERON:UBERON_0001155]

Donor Information

Age55
Age CategoryAdult
SexFemale
Subtype FeaturesMSI

Disease Information

DiseaseColon adenocarcinoma
LineageBowel
SubtypeColon Adenocarcinoma
OncoTree CodeCOAD

DepMap Information

Source TypeRIKEN
Source IDACH-000998_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Pro47Pro (c.141G>A)Heterozygous-Unknown, Unknown
MutationSimpleKRASp.Pro140His (c.419C>A)Heterozygous-Unknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,11,14
D12S391
19,20
D13S317
9,11
D16S539
9
D18S51
12,13
D19S433
12,14.2
D21S11
31
D2S1338
18
D3S1358
16,17
D5S818
11,12,13
D7S820
10,12,13
D8S1179
15,17
FGA
21,22
Penta D
10,11
Penta E
11,14
TH01
7,8
TPOX
8,12
vWA
18,21
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Genomic determinants of protein abundance variation in colorectal cancer cells.

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Choudhary J.S.

Cell Rep. 20:2201-2214(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

5-fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency.

Bracht K., Nicholls A.M., Liu Y., Bodmer W.F.

Br. J. Cancer 103:340-346(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).